• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

    8.980 +1.610 (+21.85%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,749,118
    Open 6.720
    Bid (Size) 8.940 (100)
    Ask (Size) 9.650 (100)
    Prev. Close 7.370
    Today's Range 6.720 - 9.940
    52wk Range 3.510 - 10.38
    Shares Outstanding 114,010,448
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Karyopharm (KPTI) Q4 2025 Earnings Call Transcript ↗
    Karyopharm (KPTI) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Derivatives Earnings
    Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q4 Revenue Miss and Wider Loss, Stock Falls in Pre-Market ↗
    Via Chartmill

    Performance

    YTD
    +24.9%
    +24.9%
    1 Month
    +9.6%
    +9.6%
    3 Month
    +60.6%
    +60.6%
    6 Month
    +101.8%
    +101.8%
    1 Year
    +0.1%
    +0.1%

    More News

    Read More
    News headline image
    Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q3 2025 Revenue Beat and Earnings Miss ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Earnings Scheduled For November 3, 2025 ↗
    Via Benzinga
    News headline image
    Karyopharm Therapeutics Earnings Preview ↗
    Via Benzinga
    News headline image
    This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
    Via Benzinga
    News headline image
    Earnings Outlook For Karyopharm Therapeutics ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For May 12, 2025 ↗
    Via Benzinga
    News headline image
    Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026 ↗
    Via Benzinga
    News headline image
    These stocks that are showing activity before the opening bell on Wednesday. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    Top movers analysis in the middle of the day on 2025-08-15: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 11, 2025 ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    Here are the top movers in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Traders are paying attention to the gapping stocks in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Karyopharm Therapeutics (KPTI) Q4 2024 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings

    Frequently Asked Questions

    Is Karyopharm Therapeutics Inc. - Common Stock publicly traded?
    Yes, Karyopharm Therapeutics Inc. - Common Stock is publicly traded.
    What exchange does Karyopharm Therapeutics Inc. - Common Stock trade on?
    Karyopharm Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Karyopharm Therapeutics Inc. - Common Stock?
    The ticker symbol for Karyopharm Therapeutics Inc. - Common Stock is KPTI on the Nasdaq Stock Market
    What is the current price of Karyopharm Therapeutics Inc. - Common Stock?
    The current price of Karyopharm Therapeutics Inc. - Common Stock is 8.980
    When was Karyopharm Therapeutics Inc. - Common Stock last traded?
    The last trade of Karyopharm Therapeutics Inc. - Common Stock was at 02/12/26 04:00 PM ET
    What is the market capitalization of Karyopharm Therapeutics Inc. - Common Stock?
    The market capitalization of Karyopharm Therapeutics Inc. - Common Stock is 1.02B
    How many shares of Karyopharm Therapeutics Inc. - Common Stock are outstanding?
    Karyopharm Therapeutics Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.